The mRNA technology behind Moderna’s Covid vaccine reaches the flu
A researcher works in the lab at the Moderna Inc headquarters in Cambridge, Massachusetts, on 26 March 2024. Photograph: Adam Glanzman/Bloomberg via Getty ImagesView image in fullscreenA researcher works in the lab at the Moderna Inc headquarters in Cambridge, Massachusetts, on 26 March 2024. A then top FDA official blocked the company’s application, a sign of the agency’s heightened vaccine scrutiny under the health secretary, Robert F Kennedy Jr.
- ▪A researcher works in the lab at the Moderna Inc headquarters in Cambridge, Massachusetts, on 26 March 2024.
- ▪Photograph: Adam Glanzman/Bloomberg via Getty ImagesView image in fullscreenA researcher works in the lab at the Moderna Inc headquarters in Cambridge, Massachusetts, on 26 March 2024.
- ▪A then top FDA official blocked the company’s application, a sign of the agency’s heightened vaccine scrutiny under the health secretary, Robert F Kennedy Jr.
The Guardian — US files mainly under news. We currently carry 626 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Guardian — US |
| Canonical URL | https://www.theguardian.com/us-news/2026/aug/06/flu-shot-covid-moderna-mrna-mflusiva |
| Publication time | Thu, 06 Aug 2026 13:56:28 GMT |
| Retrieval time | 2026-08-06T14:10:41.773Z |
| Last seen | 2026-08-06T14:10:41.773Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | fuTGw6hT9VJQ · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
A researcher works in the lab at the Moderna Inc headquarters in Cambridge, Massachusetts, on 26 March 2024. Photograph: Adam Glanzman/Bloomberg via Getty ImagesView image in fullscreenA researcher works in the lab at the Moderna Inc headquarters in Cambridge, Massachusetts, on 26 March 2024. Photograph: Adam Glanzman/Bloomberg via Getty ImagesUS newsThe mRNA technology behind Moderna’s Covid vaccine reaches the fluThe mFlusiva vaccine for older people is first made with mRNA platform key to ending coronavirus pandemicAssociated PressThu 6 Aug 2026 09.56 EDTLast modified on Thu 6 Aug 2026 10.09 EDTSharePrefer the Guardian on GoogleThe Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — US.
Discussion
0 commentsMore from The Guardian — US
